Sundrug Co.,Ltd. (TYO:9989)

Sundrug Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	45,803	43,569	41,261	37,710	34,675
Depreciation & Amortization	18,760	17,282	15,127	12,068	10,209
Loss (Gain) From Sale of Assets	900	998	856	877	282
Loss (Gain) on Equity Investments	1,258	1,567	-	-	-
Other Operating Activities	-13,908	-12,754	-13,437	-9,748	-13,076
Change in Accounts Receivable	-2,336	-3,238	-4,515	-2,679	-693
Change in Inventory	-11,652	-7,330	-8,427	-7,199	-34
Change in Accounts Payable	3,909	3,198	3,454	4,652	106
Change in Other Net Operating Assets	563	-2,128	6,869	1,699	213
Operating Cash Flow	43,297	41,164	41,188	37,380	31,682
Operating Cash Flow Growth	5.18%	-0.06%	10.19%	17.98%	-0.25%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-30,336	-33,451	-36,426	-24,789	-18,825
Cash Acquisitions	-	-	-	-1,004	-
Sale (Purchase) of Intangibles	-800	-815	-1,799	-1,324	-964
Investment in Securities	-	-	-35,377	-	-
Other Investing Activities	-677	-321	-1,043	-568	318
Investing Cash Flow	-32,076	-35,373	-74,850	-28,512	-20,659

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	-	35,000	-	-
Long-Term Debt Issued	14,000	40,000	-	-	-
Total Debt Issued	14,000	40,000	35,000	-	-
Short-Term Debt Repaid	-	-34,000	-	-80	-
Long-Term Debt Repaid	-4,450	-2,333	-	-7,191	-
Total Debt Repaid	-4,450	-36,333	-	-7,271	-
Net Debt Issued (Repaid)	9,550	3,667	35,000	-7,271	-
Common Dividends Paid	-15,202	-14,266	-12,511	-10,053	-8,187
Other Financing Activities	-1	-1	-2	-2	-
Financing Cash Flow	-5,653	-10,600	22,487	-17,326	-8,187

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Miscellaneous Cash Flow Adjustments	-1	66	2	-	-1
Net Cash Flow	5,567	-4,743	-11,173	-8,458	2,835

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	12,961	7,713	4,762	12,591	12,857
Free Cash Flow Growth	68.04%	61.97%	-62.18%	-2.07%	-19.36%
Free Cash Flow Margin	1.54%	0.96%	0.63%	1.82%	1.98%
Free Cash Flow Per Share	110.80	65.94	40.72	107.68	109.96
Levered Free Cash Flow	5,124	689.13	-3,788	11,715	10,186
Unlevered Free Cash Flow	5,364	791.63	-3,768	11,738	10,192

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	370	163	4	6	-
Cash Income Tax Paid	14,289	13,183	13,911	10,123	13,083
Change in Working Capital	-9,516	-9,498	-2,619	-3,527	-408

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error